FR EA

Contract analysis

Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.

Contract analysis / closing-binder-index.docx
closing-binder-index.docx
1018-00004 · 1 clauses
High · 1 Medium · 0 Standard · 0
CALDERWOOD & HARKNESS LLP 280 Park Avenue, 34th Floor New York, New York 10017 High
⚑ Non-compete / exclusivity restraint
CALDERWOOD & HARKNESS LLP 280 Park Avenue, 34th Floor New York, New York 10017 CLOSING BINDER INDEX AND TABLE OF CONTENTS Master Clinical Trial Agreement and Ancillary Agreements Protocol PPC-4871-III (CLARION — Clinical Assessment of Response with Longitudinal Investigation in ONcology) Between PENTERRA PHARMACEUTICALS CORP. (Sponsor) and VERIDIAN HEALTH RESEARCH NETWORK, INC. (Site Network) Signing Date: June 28, 2